193 related articles for article (PubMed ID: 8445034)
21. Modulation of 11beta-hydroxysteroid dehydrogenase isozymes by growth hormone and insulin-like growth factor: in vivo and in vitro studies.
Moore JS; Monson JP; Kaltsas G; Putignano P; Wood PJ; Sheppard MC; Besser GM; Taylor NF; Stewart PM
J Clin Endocrinol Metab; 1999 Nov; 84(11):4172-7. PubMed ID: 10566668
[TBL] [Abstract][Full Text] [Related]
22. Congenital deficiency of 11beta-hydroxysteroid dehydrogenase (apparent mineralocorticoid excess syndrome): diagnostic value of urinary free cortisol and cortisone.
Palermo M; Delitala G; Mantero F; Stewart PM; Shackleton CH
J Endocrinol Invest; 2001 Jan; 24(1):17-23. PubMed ID: 11227727
[TBL] [Abstract][Full Text] [Related]
23. Urinary cortisol metabolites in the assessment of peripheral thyroid hormone action: overt and subclinical hypothyroidism.
Vantyghem MC; Ghulam A; Hober C; Schoonberg C; D'Herbomez M; Racadot A; Boersma A; Lefebvre J
J Endocrinol Invest; 1998 Apr; 21(4):219-25. PubMed ID: 9624595
[TBL] [Abstract][Full Text] [Related]
24. Enhanced 11beta-hydroxysteroid dehydrogenase type 1 activity in stress adaptation in the guinea pig.
Quinkler M; Troeger H; Eigendorff E; Maser-Gluth C; Stiglic A; Oelkers W; Bähr V; Diederich S
J Endocrinol; 2003 Feb; 176(2):185-92. PubMed ID: 12553867
[TBL] [Abstract][Full Text] [Related]
25. Tissue-specific dysregulation of cortisol metabolism in human obesity.
Rask E; Olsson T; Söderberg S; Andrew R; Livingstone DE; Johnson O; Walker BR
J Clin Endocrinol Metab; 2001 Mar; 86(3):1418-21. PubMed ID: 11238541
[TBL] [Abstract][Full Text] [Related]
26. Does central obesity reflect "Cushing's disease of the omentum"?
Bujalska IJ; Kumar S; Stewart PM
Lancet; 1997 Apr; 349(9060):1210-3. PubMed ID: 9130942
[TBL] [Abstract][Full Text] [Related]
27. Cortisol metabolism after weight loss: associations with 11 β-HSD type 1 and markers of obesity in women.
Rask E; Simonyte K; Lönn L; Axelson M
Clin Endocrinol (Oxf); 2013 May; 78(5):700-5. PubMed ID: 22233384
[TBL] [Abstract][Full Text] [Related]
28. 11 beta-Hydroxysteroid dehydrogenase deficit: a rare cause of arterial Hypertension. Diagnosis and therapeutic approach in two young brothers.
Gourmelen M; Saint-Jacques I; Morineau G; Soliman H; Julien R; Fiet J
Eur J Endocrinol; 1996 Aug; 135(2):238-44. PubMed ID: 8810740
[TBL] [Abstract][Full Text] [Related]
29. Increased diurnal plasma concentrations of cortisone in depressed patients.
Weber B; Lewicka S; Deuschle M; Colla M; Vecsei P; Heuser I
J Clin Endocrinol Metab; 2000 Mar; 85(3):1133-6. PubMed ID: 10720051
[TBL] [Abstract][Full Text] [Related]
30. Lack of relationship between 11beta-hydroxysteroid dehydrogenase setpoint and insulin sensitivity in the basal state and after 24h of insulin infusion in healthy subjects and type 2 diabetic patients.
Kerstens MN; Riemens SC; Sluiter WJ; Pratt JJ; Wolthers BG; Dullaart RP
Clin Endocrinol (Oxf); 2000 Apr; 52(4):403-11. PubMed ID: 10762282
[TBL] [Abstract][Full Text] [Related]
31. 11beta-hydroxysteroid dehydrogenase activity in proteinuric patients and the effect of angiotensin-II receptor blockade.
Kerstens MN; Buter H; Navis GJ; Dullaart RP
Eur J Clin Invest; 2002 Jul; 32(7):513-8. PubMed ID: 12153552
[TBL] [Abstract][Full Text] [Related]
32. Human kidney 11 beta-hydroxysteroid dehydrogenase is a high affinity nicotinamide adenine dinucleotide-dependent enzyme and differs from the cloned type I isoform.
Stewart PM; Murry BA; Mason JI
J Clin Endocrinol Metab; 1994 Aug; 79(2):480-4. PubMed ID: 8045966
[TBL] [Abstract][Full Text] [Related]
33. Type 2 11 beta-hydroxysteroid dehydrogenase in human fetal tissues.
Stewart PM; Murry BA; Mason JI
J Clin Endocrinol Metab; 1994 Jun; 78(6):1529-32. PubMed ID: 8200959
[TBL] [Abstract][Full Text] [Related]
34. [Decreased activity of 11-beta-hydroxysteroid dehydrogenase in patients with Cushing's syndrome].
Stiefel P; Jiménez L; García-Morillo JS; Leal A; Villar J; Carneado J
Med Clin (Barc); 2000 Jun; 115(3):90-2. PubMed ID: 10965482
[TBL] [Abstract][Full Text] [Related]
35. Cortisol metabolism in depressed patients and healthy controls.
Römer B; Lewicka S; Kopf D; Lederbogen F; Hamann B; Gilles M; Schilling C; Onken V; Frankhauser P; Deuschle M
Neuroendocrinology; 2009; 90(3):301-6. PubMed ID: 19713693
[TBL] [Abstract][Full Text] [Related]
36. Apparent mineralocorticoid excess causing hypertension and hypokalemia in children.
New MI; Stoner E; DiMartino-Nardi J
Clin Exp Hypertens A; 1986; 8(4-5):751-72. PubMed ID: 3463439
[TBL] [Abstract][Full Text] [Related]
37. Urinary cortisol to cortisone metabolites in hypertensive obese children.
Csábi GY; Juricskay S; Molnár D
J Endocrinol Invest; 2000; 23(7):435-9. PubMed ID: 11005267
[TBL] [Abstract][Full Text] [Related]
38. Quantification of cortisol inactivation in cirrhosis of the liver.
Vogeser M; Fischer G; Jacob K
Exp Clin Endocrinol Diabetes; 1998; 106(5):410-4. PubMed ID: 9831307
[TBL] [Abstract][Full Text] [Related]
39. Deficient inactivation of cortisol by 11 beta-hydroxysteroid dehydrogenase in essential hypertension.
Walker BR; Stewart PM; Shackleton CH; Padfield PL; Edwards CR
Clin Endocrinol (Oxf); 1993 Aug; 39(2):221-7. PubMed ID: 8370136
[TBL] [Abstract][Full Text] [Related]
40. Serum cortisol/cortisone ratio after Synacthen stimulation.
Vogeser M; Zachoval R; Jacob K
Clin Biochem; 2001 Jul; 34(5):421-5. PubMed ID: 11522281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
